共 250 条
[1]
Kim SW(2009)Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study Bone Marrow Transplant 43 611-617
[2]
Mori SI(2013)Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation Blood 122 3871-3878
[3]
Tanosaki R(2013)Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabine J Clin Oncol 31 701-709
[4]
Fukuda T(2008)Optimal prevention of seizures induced by high-dose busulfan Pharmacotherapy 28 1502-1510
[5]
Kami M(2017)Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients J Oncol Pharm Pract 23 344-349
[6]
Sakamaki H(2015)Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantation Int J Hematol 101 497-504
[7]
Yamashita T(2013)Clonazepam for seizure prophylaxis in adult patients treated with high dose busulfan Int J Clin Pharm 35 339-343
[8]
Kodera Y(1996)Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients J Clin Oncol 14 1484-1494
[9]
Terakura S(2005)Significant induction of cyclophosphamide and thiotepa metabolism by phenytoin Cancer Chemother Pharmacol 55 507-510
[10]
Taniguchi S(2012)Levetiracetam for busulfan-induced seizure prophylaxis in children undergoing hematopoietic stem cell transplantation Pediatr Blood Cancer 59 762-764